StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.51+0.01 (+2.27%)

Close on Nov 20, 2026Market cap $13.96MP/E –Yield –

Citius Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2018 it was $0.

Annual gross profit

PeriodPeriod endValueChange
FY2018Sep 30, 2018$0–
FY2017Sep 30, 2017$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$1.00M–
Q2 FY2026CQ1 2026Mar 31, 2026$1.34M–
Q1 FY2026CQ4 2025Dec 31, 2025$3.15M–

More Citius Pharmaceuticals figures

See a number that looks wrong?